Colorectal cancer is the third-most diagnosed cancer and second-leading cause of cancer-related deaths among adults in the U.S., according to the paper.
The rise of colon and breast cancer in young adults westfaironline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from westfaironline.com Daily Mail and Mail on Sunday newspapers.
When it comes to cancer, one cannot overestimate the importance of early detection. Especially when it comes to colorectal and endometrial cancer that even big pharma companies don’t have a good track record at treating. At the end of last year, Merck (NYSE: MRK) provided a non-optimistic update regarding its Phase 3 LEAP-001 trial that evaluates a combined treatment that uses its blockbuster cancer drug, Keytruda, against advanced endometrial carcinoma. The failure of Merck to improve the treat
BERKELEY, Calif. and MAINZ, Germany, Feb. 27, 2024 (GLOBE NEWSWIRE) Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a leader in molecular genetics diagnostic solutions for early cancer detection, is proud to announce its participation as an exhibitor at the esteemed Gynecology Congress (‘Gynäkologie und Geburtshilfe aktuell’) in Stuttgart, Germany, on March 1st. This engagement signifies the company's commitment to advancing colorectal cancer (CRC) screening through their i
EQS-News: Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.